These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11904958)

  • 1. [Overview of recent monoclonal antibody therapy].
    Ozeki I; Imai K
    Nihon Rinsho; 2002 Mar; 60(3):457-62. PubMed ID: 11904958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
    Reverter JC; Béguin S; Kessels H; Kumar R; Hemker HC; Coller BS
    J Clin Invest; 1996 Aug; 98(3):863-74. PubMed ID: 8698879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring platelet GPIIb/IIIa antagonist therapy.
    Coller BS
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S81-6. PubMed ID: 10070826
    [No Abstract]   [Full Text] [Related]  

  • 4. The monoclonal antibody, 7E3 and treatment of coronary artery disease.
    Talley JD
    J Ark Med Soc; 1996 Feb; 92(9):453-4. PubMed ID: 8742163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 6. [Brief overview on the studies of monoclonal antibody].
    Tsukagoshi S
    Nihon Rinsho; 2002 Mar; 60(3):435-8. PubMed ID: 11904954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.
    Gold HK; Gimple LW; Yasuda T; Leinbach RC; Werner W; Holt R; Jordan R; Berger H; Collen D; Coller BS
    J Clin Invest; 1990 Aug; 86(2):651-9. PubMed ID: 2384607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to constant domains of therapeutic monoclonal antibodies: anti-hinge antibodies in immunogenicity testing.
    Rispens T; de Vrieze H; de Groot E; Wouters D; Stapel S; Wolbink GJ; Aarden LA
    J Immunol Methods; 2012 Jan; 375(1-2):93-9. PubMed ID: 21986105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases.
    Chanock RM; Crowe JE; Murphy BR; Burton DR
    Infect Agents Dis; 1993 Jun; 2(3):118-31. PubMed ID: 8173784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS; Badakere SS
    J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies.
    Escher R; Vogel M; Escher G; Miescher S; Stadler BM; Berchtold P
    J Autoimmun; 2002 Feb; 18(1):71-81. PubMed ID: 11869049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
    Mazurov AV; Pevzner DV; Antonova OA; Byzova TV; Khaspekova SG; Semenov AV; Vlasik TN; Samko AN; Staroverov II; Ruda MY
    Platelets; 2002 Dec; 13(8):465-77. PubMed ID: 12487780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering antibodies for therapy.
    Presta LG
    Curr Pharm Biotechnol; 2002 Sep; 3(3):237-56. PubMed ID: 12164480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.
    Liu Y; Zheng M; Lai Z; Xiong D; Fan D; Xu Y; Peng H; Shao X; Xu Y; Yang M; Wang J; Liu H; Xie Y; Yang C; Zhu Z
    Cancer Lett; 2004 Mar; 205(2):143-53. PubMed ID: 15036646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.
    Abrams CS; Cines DB
    Curr Hematol Rep; 2004 Mar; 3(2):143-7. PubMed ID: 14965491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on the antiplatelet effects of a humanized anti-platelet glycoprotein IIb/IIIa antibody (YM337) and ReoPro under flow conditions.
    Kuwahara M; Sugimoto M; Tsuji S; Miyata S; Nishio K; Kaku S; Suzuki K; Kawasaki T; Yoshioka A
    Thromb Haemost; 1998 Jul; 80(1):28-31. PubMed ID: 9684780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GPIIb/IIIa inhibitor].
    Ikeda Y
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1174-81. PubMed ID: 10771692
    [No Abstract]   [Full Text] [Related]  

  • 20. Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4.
    Fontayne A; Vanhoorelbeke K; Pareyn I; Van Rompaey I; Meiring M; Lamprecht S; Roodt J; Desmet J; Deckmyn H
    Thromb Haemost; 2006 Nov; 96(5):671-84. PubMed ID: 17080226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.